Immediate Impact

27 standout
Sub-graph 1 of 14

Citing Papers

Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Alternative splicing and related RNA binding proteins in human health and disease
2024 Standout
2 intermediate papers

Works of Lingfang Xia being referenced

Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study
2022
HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway
2021

Author Peers

Author Last Decade Papers Cites
Lingfang Xia 198 166 160 33 457
Heung Yeol Kim 189 170 178 35 498
Lucía González‐Cortijo 184 173 103 26 403
W. Kleine 177 185 122 33 442
Zoltán Hernádi 94 167 129 39 500
Nicoletta D’Alessandris 312 227 104 50 456
Brian Orr 96 128 111 25 391
Lucia Musacchio 147 183 261 41 493
Maria Bjurberg 222 207 126 36 512
Yoko Hasumi 115 96 131 29 508
Maria-Pilar Barretina-Ginesta 181 217 225 31 470

All Works

Loading papers...

Rankless by CCL
2026